Skip to main content
EJNMMI Radiopharmacy and Chemistry
Fig. 4 | EJNMMI Radiopharmacy and Chemistry

Fig. 4

From: 44Sc for labeling of DOTA- and NODAGA-functionalized peptides: preclinical in vitro and in vivo investigations

Fig. 4

Biodistribution data obtained 2 h after injection of ~5 MBq (~1 nmol) 44Sc- and 68Ga-labeled DOTA-RGD (a) and NODAGA-RGD (b) and ~5 MBq (~1 nmol) DOTA-NOC (c) and NODAGA-NOC (d). Data bars represent the average ± SD of values obtained from n = 3 mice (* significantly different uptake of the 44Sc-labeled peptide compared to the 68Ga-labeled peptide, p <0.05)

Back to article page